CoChat

A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics

Open access

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.

Abstract

The rapid repurposing of antivirals is particularly pressing during pandemics. However, rapid assays for assessing candidate drugs typically involve in vitro screens and cell lines that do not recapitulate human physiology at the tissue and organ levels. Here we show that a microfluidic bronchial-airway-on-a-chip lined by highly differentiated human bronchial-airway epithelium and pulmonary endothelium can model viral infection, strain-dependent virulence, cytokine production and the recruitment of circulating immune cells. In airway chips infected with influenza A, the co-administration of nafamostat with oseltamivir doubled the treatment-time window for oseltamivir. In chips infected with pseudotyped severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), clinically relevant doses of the antimalarial drug amodiaquine inhibited infection but clinical doses of hydroxychloroquine and other antiviral drugs that inhibit the entry of pseudotyped SARS-CoV-2 in cell lines under static conditions did not. We also show that amodiaquine showed substantial prophylactic and therapeutic activities in hamsters challenged with native SARS-CoV-2. The human airway-on-a-chip may accelerate the identification of therapeutics and prophylactics with repurposing potential.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41551-021-00718-9

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Research works printed but not linked: 1

  1. Chen, J. et al. Efficacies of lopinavir/ritonavir and abidol in the treatment of novel coronavirus pneumonia (in Chinese). Chin. J. Infect. Dis. 38, E008–E008 (2020).

Cited by

See all 440

Metadata

Authors
Si, L., Bai, H., Rodas, M., Cao, W., Oh, C. Y., Jiang, A., Moller, R., Hoagland, D., Oishi, K., Horiuchi, S., Uhl, S., Blanco-Melo, D., Albrecht, R. A., Liu, W.-C., Jordan, T., Nilsson-Payant, B. E., Golynker, I., Frere, J., Logue, J., Haupt, R., McGrath, M., Weston, S., Zhang, T., Plebani, R., Soong, M., Nurani, A., Kim, S. M., Zhu, D. Y., Benam, K. H., Goyal, G., Gilpin, S. E., Prantil-Baun, R., Gygi, S. P., Powers, R. K., Carlson, K. E., Frieman, M., tenOever, B. R., & Ingber, D. E.
Affiliations
  • Harvard University (US)
  • Boston Children's Hospital (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • University of Maryland, Baltimore (US)
Corresponding author
Ingber, Donald E.
Venue
Nature Biomedical Engineering
Published
2021-05-03
Volume
5
Issue
8
Pages
815-829
ISSN
2157-846X (ISSN-L)
OpenAlex
W3157288445
Cited by
440
References
65
Citations by year
2026: 58 · 2025: 76 · 2024: 99 · 2023: 84 · 2022: 77 · 2021: 46
FWCI
23.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Biomedical Engineering (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Bill and Melinda Gates Foundation
  • Harvard University
  • National Institutes of Health (NCATS 1-UH3-HL-141797-01)
  • Centers for Disease Control and Prevention
  • Defense Advanced Research Projects Agency (W911NF-12-2-0036, W911NF‐16‐C‐0050)
  • Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University
  • National Heart, Lung, and Blood Institute (UG3HL141797, UH3HL141797)
  • National Center for Advancing Translational Sciences (1-UH3-HL-141797-01)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
Keywords
human bronchial epithelium, pulmonary endothelium, antiviral drug repurposing, influenza A virus, SARS-CoV-2, nafamostat, oseltamivir, amodiaquine, hydroxychloroquine, organ-on-a-chip, prophylaxis, hamster challenge model, cytokine production, immune cell recruitment, viral infection modeling
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Testing, COVID-19 Drug Treatment, Animals, Antiviral Agents, Cell Line, Female, Cricetinae, Humans, Male, Green Fluorescent Proteins, Virus Internalization, Lab-On-A-Chip Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. https://app.cochat.ai/papers/10.1038/s41551-021-00718-9
The paper
Si, L., Bai, H., Rodas, M., Cao, W., Oh, C. Y., Jiang, A., Moller, R., Hoagland, D., Oishi, K., Horiuchi, S., Uhl, S., Blanco-Melo, D., Albrecht, R. A., Liu, W.-C., Jordan, T., Nilsson-Payant, B. E., Golynker, I., Frere, J., Logue, J., . . . Ingber, D. E. (2021). A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-021-00718-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.